In this issue:
– COBRRA: bleeding with rivaroxaban vs. apixaban in acute VTE
– ADJUST-DVT: age-adjusted D-dimer thresholds to exclude DVT
– A four-factor prothrombin complex concentrate in factor Xa inhibitor-associated GI bleeding
– Mezagitamab ITP: mezagitamab in primary ITP
– TRAKJAK: a pre-test PV probability score to guide JAK2 alteration screening
– CARMEN-France: incidence/ management of venous thrombosis in ITP
– Reversal agents for DOAC associated bleeding in the UK
– Anti-Xa DOAC monotherapy after percutaneous intervention with drug-eluting stents in AF
– DOAC under-dosing in AF and ischaemic stroke in Australia
– Disease burden in non transfusion-dependent α- and β-thalassaemia
Expert contributor
Nicola Eaddy specialises in thrombosis and haemostasis at Auckland City Hospital as part of the Thrombosis Unit and Haemophilia Unit. She is involved in clinical trials in haemostasis and has an interest in cancer and thrombosis.
Expert contributor
James Liang is a clinical and pathology haematologist with special interest in adult haematological cancer while also managing general haematological conditions such as thrombosis and haemostasis. After completing his medical degrees in 2005 from the University of Auckland, James continued his medical training in the Auckland region. In 2015 he was awarded a research fellowship […]
Expert contributor
Gordon Royle is a graduate of Otago Medical School. After moving to Auckland he undertook a Masters in Molecular Biology, and went on to train in Haematology. For the last 19 years he has been working as a Haematologist and researcher at Middlemore Hospital, and is a senior lecturer at Auckland University’s School of Medicine. […]
Stay up to date with our latest clinical information.
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.